Northern Trust
WINT

Northern Trust’s Windtree Therapeutics Inc WINT Stock Holding History

Northern Trust’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-16,209
Closed -$19K – 4349
2017
Q1 		$19K Buy
+16,209
New +$21.1K ﹤0.01% 4160
2016
Q1 		– Sell
-8,598
Closed -$26K – 4310
2015
Q4 		$26K Sell
8,598
-1,105
-11% -$4.53K ﹤0.01% 4145
2015
Q3 		$41K Hold
9,703
– – ﹤0.01% 4110
2015
Q2 		$92K Sell
9,703
-1,737
-15% -$24.4K ﹤0.01% 3969
2015
Q1 		$191K Sell
11,440
-20
-0.2% -$394 ﹤0.01% 3889
2014
Q4 		$186K Hold
11,460
– – ﹤0.01% 3835
2014
Q3 		$295K Sell
11,460
-1,670
-13% -$40.3K ﹤0.01% 3718
2014
Q2 		$326K Buy
13,130
+1,668
+15% +$42.6K ﹤0.01% 3718
2014
Q1 		$345K Buy
11,462
+1,156
+11% +$38.9K ﹤0.01% 3646
2013
Q4 		$325K Buy
10,306
+2,587
+34% +$80.9K ﹤0.01% 3593
2013
Q3 		$212K Sell
7,719
-23,919
-76% -$580K ﹤0.01% 3649
2013
Q2 		$673K Buy
+31,638
New +$779K ﹤0.01% 3394

Other funds holding WINT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Northern Trust's WINT Position: Q2 2017 in Review

Northern Trust sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 16,209 shares — an estimated $19K sold.

Northern Trust first reported a position in WINT in Q2 2013 and held it in 12 quarters. The position peaked at $673K in Q2 2013. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Northern Trust reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Northern Trust sold 16,209 Windtree Therapeutics Inc shares in Q2 2017, an estimated $19K.
  • Northern Trust first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 12 quarters.
  • Northern Trust's Windtree Therapeutics Inc position peaked at $673K in Q2 2013.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Northern Trust's 13F filing for Q2 2017, filed 11 Aug 2017.